News Sentiment

NRSN sentiment intelligence

Neurosense Therapeutics Ltd news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 57 Balanced news tone 53 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 0.68 Week of 17 Jul 2026
Weighted tone 57/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

83/100 classification confidence.

Company focus 44

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-6.1% over one week, -15.0% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

NeuroSense Reports 14.9-Month Median Survival Benefit for PrimeC

Market Reaction

Price moving ahead of tone

67/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 83/100 classification
One-week reaction -6.1% Price reacting lower
Trend fit Trend inactive -15.0% over four weeks
Fair value -36.9% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 12
Neutral 40
Negative 1

Relevance

Why the article matched

Direct first
Direct company coverage 44
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
TradingView 11
Stock Titan 9
PR Newswire 8
Market source 6
TradingKey 6
dars.gov.et 3
MT Newswires 3
simplywall.st 2

Event Lens

What the news is about

Classified themes
Market update 33
Earnings 18
Analyst action 1
Capital return 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-53 of 53
TradingKey Direct company coverage

Neurosense Therapeutics Ltd (NRSN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution — TradingKey

This article from TradingKey concerns Neurosense Therapeutics Ltd (NRSN) and its revenue breakdown. However, it states that relevant data regarding business segments, regional revenue, and profit contribution have not yet been disclosed by the company. The page provides general c

Tone
Neutral 50/100
Event
Earnings
Published
19 Jun 2026 03:39
Source
TradingKey
TradingKey Direct company coverage

Neurosense Therapeutics Ltd (NRSN) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Neurosense Therapeutics Ltd (NRSN), outlining both major individual and corporate shareholders, as well as institutional holdings. Key individual investors like Ben-Noon (Alon) and Rimon Gold Assets Ltd hold significant proportion

Tone
Neutral 50/100
Event
Market update
Published
19 Jun 2026 01:39
Source
TradingKey
TradingKey Direct company coverage

Neurosense Therapeutics Ltd (NRSNW) Institutional Confidence

This article provides details on the institutional confidence score for Neurosense Therapeutics Ltd (NRSNW), indicating a current score of 0.00 with no change from the previous score. It lists several institutional shareholders and their recent activity, including Clear Street LL

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 18:10
Source
TradingKey
TradingKey Direct company coverage

Neurosense Therapeutics Ltd (NRSNW) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Neurosense Therapeutics Ltd (NRSNW). It indicates that relevant data for EPS, revenue, and net profit forecasting has not been disclosed by the company yet. The stock is currently trading at $0.091, with a 9.53% increase.

Tone
Neutral 50/100
Event
Earnings
Published
18 Jun 2026 17:10
Source
TradingKey
TradingKey Direct company coverage

Neurosense Therapeutics Ltd (NRSNW) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Neurosense Therapeutics Ltd (NRSNW), focusing on key metrics like P/E, P/B, P/S, and P/CF ratios. However, it indicates that relevant data for these metrics have not yet been disclosed by the company. The current stock price for NRSN

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 17:10
Source
TradingKey